Sekar Kathiresan
CIK 1864112 · Chief Executive Officer · last filed 2025-09-24
Sekar Kathiresan is a Chief Executive Officer who has filed 22 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for MAZE, was dated Sep 24, 2025. Across all open-market trades the lifetime net is −$11.2M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
22
-$11.18M
Holdings By Company
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-09-24 | MAZE | Grant (A) | — | $0 | EDGAR |
| 2025-07-28 | Verve Therapeutics, Inc. (VERV) Delisted | Mixed | −700,425 | $0 | EDGAR |
| 2025-06-06 | RLAY | Grant (A) | — | $0 | EDGAR |
| 2025-04-03 | Verve Therapeutics, Inc. (VERV) Delisted | Mixed | +23,178 | -$40.8K | EDGAR |
| 2025-01-10 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-12-04 | Verve Therapeutics, Inc. (VERV) Delisted | Gift (G) | — | $0 | EDGAR |
| 2024-07-02 | Verve Therapeutics, Inc. (VERV) Delisted | Exer (M) | +30,000 | $86.1K | EDGAR |
| 2024-06-05 | RLAY | Grant (A) | — | $0 | EDGAR |
| 2024-02-16 | Verve Therapeutics, Inc. (VERV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-01 | RLAY | Grant (A) | — | $0 | EDGAR |